Cellectar Biosciences Inc (NASDAQ:CLRB)
| 1.61 Delayed Data As of Jun 01 |  +0.07 / +4.49%Today’s Change | 1.25 Today|||52-Week Range 6.76 | -5.85% Year-to-Date |
Latest CLRB News | Press Releases
No recent news for Cellectar Biosciences Inc.
Today’s Trading
| Previous close | 1.56 |
| Today’s open | 1.63 |
| Day’s range | 1.55 - 1.65 |
| Volume | 46,324 |
| Average volume (3 months) | 55,089 |
| Market cap | $14.8M |
Data as of 2:07pm ET, 06/01/2023
Growth & Valuation
| Earnings growth (last year) | +6.71% |
| Earnings growth (this year) | +40.19% |
| Earnings growth (next 5 years) | +14.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.01 |
Competitors
Data as of 3:59pm ET, 06/01/2023
Financials
| Next reporting date | August 9, 2023 |
| EPS forecast (this quarter) | -$0.67 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$28.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Florham Park, New Jersey |
Forecasts
